Skip to main content

Table 5 Multivariate analysis of factors to predict LRR

From: Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment

Parameters

Odds ratio

95% Confidence interval

P value

Clinical lymph node status

   

 N0

1

  

 N1

2.981

0.700–12.701

0.14

 N2

5.668

1.343–23.929

0.018

SBR grade

   

 1

1

  

 2

3.012

0.700–12.954

0.139

 3

3.572

0.827–15.428

0.088

 Unknown

1.541

0.259–9.157

0.634

ER

   

 Positive

1

  

 Negative

4.272

1.405–12.995

0.011

PR

   

 Positive

1

  

 Negative

1.768

0.896–3.487

0.1

Subtype

   

 HR + /HER2−

1

  

 HR + /HER2 + 

1.029

0.552–1.919

0.929

 HR−/HER2 + 

0.295

0.075–1.159

0.08

 HR−/HER2−

0.329

0.083–1.313

0.115

pCR

   

 Yes

1

  

 No

2.247

1.146–4.407

0.019

  1. HR hormone receptor, HER-2 human epidermal growth factor receptor 2, LRR locoregional recurrence, pCR pathological complete response
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us